Spanish pharmacists draw up a consensus document to govern monitoring of hazardous drugs in hospital pharmacies Ten recommendations include aspects related to the drugs to be monitored; the areas to be monitored; when samples should be taken; risk determination and… Read more
News
European Parliament Employment Committee Exchange of Views on CMD4 – 23 Feb 2021
Protection of workers from exposure to carcinogens or mutagens at work – CMD4 Speakers from the Stop Cancer at Work campaign and other experts gave presentations to the Employment and Social Affairs Committee of the European Parliament alongside Employment Commissioner… Read more
The EU Committee on Employment and Social Affairs holds exchange of views on CMD4
Today the EU Committee on Employment and Social Affairs (EMPL) is holding an exchange of views on the ‘Protection of workers from exposure to carcinogens or mutagens at work’ as part of the EU’s proposal to amend the Carcinogens and… Read more
As part of World Patient Safety Day, the WHO produce a new charter: ‘Healthcare worker safety: a priority for patient safety’
As part of World Patient Safety Day in September 2020, the World Health Organisation presented a new Charter: ‘healthcare worker safety: a priority for patient safety’. The Charter is dedicated to the millions of health workers fighting COVID-19 across the… Read more
Medication Errors: The Second Victim
“All medication errors are potentially avoidable. They can thus be greatly reduced or even prevented by improving the systems and practices of medication, including ordering, prescription, preparation, dispensing, administration and monitoring.” World Health Organization (WHO) 2017. (1) The Problem The… Read more
Press statement for launch of Stop Cancer at Work Campaign
Today a broad coalition of professional organisations, trades unions and patient groups are launching the Stop Cancer at Work Campaign to ensure that the current fourth revision of the Carcinogens and Mutagens Directive (CMD) includes groups of… Read more
HOSPEEM-EPSU position on the European Commission study supporting the assessment of different options concerning the protection of workers from exposure to hazardous medicinal products
Source: HOSPEEM. Brussels, 24/09/2020 Every year more than 12.7 million healthcare workers in Europe, including 7.3 million nurses, are potentially exposed to carcinogenic, mutagenic and reprotoxic hazardous drugs. Studies show that hospital workers who handle cytotoxic drugs are three… Read more
Position Statement on Rapid Antigen Point of Care Tests for COVID and Influenza
A number of new diagnostic tests for SARS CoV2 are being and will be launched in the coming weeks with rapid point of care antigen tests being the most important technological innovation. Some months ago, the US Federal Drug Administration… Read more
COVID and Influenza Preparedness in Europe
The COVID-19 pandemic and its repercussions will continue for some time and is likely to continue to place an ongoing burden on already stretched healthcare workers and patients in Europe, which will be exacerbated if it coincides with the seasonal… Read more
COVID-19 Vaccination Programme
COVID-19 vaccination is the most important global healthcare initiative at the moment and by the end of 2020/beginning of 2021, it is expected that pharmaceutical companies will start to deliver the first vaccines in Europe but probably not enough for… Read more
